The new immunoassays Simoa and ELLA have increased sensitivity and allow NfL quantification in blood, avoiding the need for invasive lumbar punctures to obtain CSF (where NfL levels are estimated to be ∼40 times higher) and opening the door to easily incorporate NfL quantification in studies conducted in malaria-endemic settings [4]. This evidence concerns the gene NEFL and malaria.